Eczacıbaşı to acquire Turkish pharma company Gensenta for $135m
Following the acquisition, Amgen Turkey will maintain its operations and serve its patients in the region.
deal
Latest in
deal
Astellas and Sutro partner to develop immunostimulatory ADCs
Sutro could be eligible for milestone payments of up to $422.5m for each product candidate.
invoX Pharma agrees to acquire biopharma firm F-star Therapeutics for $161m
Four programmes of F-star are currently in the clinic while various other undisclosed programmes are in the developmental stage.
Galapagos to buy CellPoint, AboundBio to boost access to cell therapies
AboundBio will receive $14m from Galapagos under the agreed transaction.
Afrigen and Univercells partner to develop African-owned Covid-19 vaccine
Under the deal, an mRNA vaccine that is thermostable at refrigerator temperatures will be produced.
Pfizer to acquire 8.1% share in French firm Valneva
Pfizer intends to commence the Phase III clinical trial of the vaccine in the third quarter of this year.
Zura Bio signs merger deal with JATT Acquisition
The boards of directors of Zura Bio and JATT granted approval for the business combination.
MD Anderson, Invectys and CTMC partner to develop CAR T cell therapy
Invectys’ researchers and the CTMC team will jointly develop an HLA-G targeted CAR T cell therapy for solid tumours.